Skip to Main content Skip to Navigation
Poster communications

Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors

Document type :
Poster communications
Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-02386511
Contributor : Carole Brunaud <>
Submitted on : Friday, November 29, 2019 - 1:04:45 PM
Last modification on : Monday, October 19, 2020 - 2:38:02 PM

Identifiers

  • HAL Id : hal-02386511, version 1

Citation

C Berthet, O Raguin, S Chalon, X Tizon, S Serrière, et al.. Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors. American Association for Cancer Research, Apr 2017, Washington, France. ⟨hal-02386511⟩

Share

Metrics

Record views

15